New Treatment Horizons for Deep Vein Thrombosis in Cancer Patients-Iris Publishers
Authored by Caio Teixeira dos Santos*
Venous thromboembolism (VTE), clinically manifested as deep vein thrombosis (DVT) or pulmonary embolism (PE). It is the third most common acute cardiovascular syndrome behind acute myocardial infarction and stroke [1]. It may occur before, during or after cancer diagnosis, with a relatively high incidence in cancer patients, ranging from 15 to 50% [2]. Thrombotic events are reported as the second leading cause of mortality in these patients; the main cause is death due to cancer itself [3]. VTE treatment when associated with cancer is complex, related to the high risk of bleeding and recurrent VTE [2]. The basis of acute VTE management in patients with or without cancer is generally equal. However, an individual management is necessary due to comorbidities, drug interactions and other kinds of approach.
Read More...Full Text
For More Articles in Advances in Cancer Research & Clinical Imaging please click on https://www.irispublishers.com/acrci/
For More Open Access Journals in Iris Publishers please click on https://irispublishers.com/journals.php
To Know indexing list of Iris Publishers please click on https://medium.com/@irispublishers/what-is-the-indexing-list-of-iris-publishers-4ace353e4eee
